Inflammaging and Brain Aging

Area of Science:

• Neuroscience
• Gerontology
• Immunology

Background:

• Increased lifespan is associated with a rise in age-related diseases, including neurodegenerative disorders.
• Brain aging involves morphological, cellular, and signaling pathway changes, leading to cognitive decline.
• Neuroinflammation and chronic systemic inflammation (inflammaging) are implicated in age-associated neurodegeneration.

Purpose of the Study:

• To explore the link between aging, neuroinflammation, and neurodegeneration.
• To investigate the role of factors like circadian clock dysfunction, gut dysbiosis, immunosenescence, and cholinergic signaling in age-related cognitive decline.
• To highlight gender differences in neurodegeneration and the potential of rejuvenation research.

Main Methods:

• Review of current research on aging, neurodegeneration, and inflammation.
• Analysis of signaling pathways and genetic factors involved in cellular senescence.
• Examination of gender-specific mechanisms in neurodegeneration, particularly glial cell involvement.

Main Results:

• Aging induces brain changes and cognitive impairments, with neuroinflammation and inflammaging playing key pathogenic roles.
• Dysfunctions in circadian rhythms, gut microbiota, immune system aging, and cholinergic signaling contribute to neurodegeneration.
• Gender differences exist in neurodegeneration susceptibility and progression, influenced by glial cells.

Conclusions:

• Interfering with pathways promoting cellular senescence may offer strategies to prevent or delay neurodegeneration.
• Further research into gender-specific mechanisms and individualized therapeutic approaches is crucial.
• Rejuvenation research holds promise for mitigating age-associated cognitive decline and neurodegenerative diseases.